Clinical trial
Retrospective Analysis of the Difference of Prognosis Between Unresectable and Recurrent Biliary Tract Cancer
NCT01294085 is registered in ClinicalTrials.gov with Kansai Hepatobiliary Oncology Group as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Retrospective Analysis of the Difference of Prognosis Between Unresectable and Recurrent Biliary Tract Cancer
- Lead sponsor
- Kansai Hepatobiliary Oncology Group
- Phase
- Observational
- Overall status
- Completed
- Start date
- November 30, 2010
- Completion date
- August 31, 2011
- Enrollment
- 300 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
biliary tract cancer